Skip to content

Lens Extraction Combined With Goniosynechialysis Versus Trabeculectomy

Effectiveness of Lens Extraction Combined With Goniosynechialysis Versus Trabeculectomy in Treating Advanced Angle-closure Glaucoma: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04703712
Enrollment
316
Registered
2021-01-11
Start date
2021-01-30
Completion date
2024-12-31
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Angle-Closure

Keywords

phacoemulsification, goniosynechialysis, trabeculectomy

Brief summary

To compare the effectiveness of lens extraction combined with goniosynechialysis and trabeculectomy in treating advanced angle-closure glaucoma.

Detailed description

Advanced angle closure glaucoma (AACG) can result in severe visual function defect or even blindness with or without acute attacks. Different from open angle glaucoma (OAG), the main principle of treatment for AACG is not only to lower intraocular pressure (IOP) but also to protect the anterior chamber angle from closing. Previously, the most common and classical treatment for AACG was trabeculectomy. However, both doctors and patients are not satisfied with this surgery because of its limited success rate due to fibrosis of the filtration pathway. Besides, trabeculectomy has various complications, such as shallow anterior chamber, choroidal effusion, suprachoroidal hemorrhage, malignant glaucoma, and bleb leakage associated endophthalmitis. In addition, patients who underwent trabeculectomy will have decreased visual acuity in a couple of years due to accelerated development of cataract. Since a thickened and anterior-positioned lens could play a crucial role in the pathogenesis of AACG, cataract surgery has also been used. Accumulative evidence shows lens extraction alone is an efficient way in treating the early stage of ACG but has limited success rate in AACG. Lens extraction combined with goniosynechialysis (LEG) has been proved to be better than lens extraction alone in re-opening the anterior chamber angle for ACG patients with extensive peripheral anterior synechia and possibly have better effect than trabeculectomy as well from our preliminary data, which has not been proved yet. Thus, this investigation is designed to compare the effect of LEG and trabeculectomy in AACG patients prospectively in 3 years of follow-up. The investigators hypothesize that LEG could have better IOP control and better visual function than trabeculectomy in long term for AACG patients.

Interventions

PROCEDURELens extraction combined with goniosynechialysis

The patients enrolled underwent phacoemulsification combined with goniosynechialysis surgery.

The patients enrolled underwent trabeculectomy surgery

Sponsors

Eye & ENT Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age between 40 years old to 80 years old 2. more than 180-degree synechial closure of anterior chamber angle on gonioscopy 3. IOP higher than 21mmHg under the use of more than two anti-glaucoma eye drops 4. mean deviation of visual field worse than -12dB on Humphrey 24-2 5. phakic eyes

Exclusion criteria

1. Snellen visual acuity worse than 0.02 2. history of ocular trauma 3. uveitis 4. previous ocular surgeries 5. significant conjunctival scar 6. visible neovascular on iris or anterior chamber angle 7. other severe eye diseases that would affect visual function significantly, such as age-related macular degeneration and pathogenic myopia.

Design outcomes

Primary

MeasureTime frameDescription
Best corrected visual acuity at three yearsthree yearsBest corrected visual acuity of participants after surgery at three years
IOP change at one yearone yearChange from baseline IOP after phacoemulsification combined with goniosynechialysis or trabeculectomy at one year.
IOP change at two yearstwo yearsChange from baseline IOP after phacoemulsification combined with goniosynechialysis or trabeculectomy at two years.
IOP change at three yearsthree yearsChange from baseline IOP after phacoemulsification combined with goniosynechialysis or trabeculectomy at three years.
Best corrected visual acuity at one monthone monthBest corrected visual acuity of participants after surgery at one month
Best corrected visual acuity at two yearstwo yearsBest corrected visual acuity of participants after surgery at two years
Best corrected visual acuity at six monthssix monthsBest corrected visual acuity of participants after surgery at six months
Best corrected visual acuity at one yearone yearBest corrected visual acuity of participants after surgery at one year
Best corrected visual acuity at three monthsthree monthsBest corrected visual acuity of participants after surgery at three months
Intraocular pressure (IOP) change at one monthone monthChange from baseline IOP after phacoemulsification combined with goniosynechialysis or trabeculectomy at one month.
IOP change at three monthsthree monthsChange from baseline IOP after phacoemulsification combined with goniosynechialysis or trabeculectomy at three months.
IOP change at six monthssix monthsChange from baseline IOP after phacoemulsification combined with goniosynechialysis or trabeculectomy at six months.

Secondary

MeasureTime frameDescription
The thickness of retinal nerve fiber layer (RNFL)one month, three months, six months, one year, two years, three yearsThe RNFL thickness measured by optical coherence topography (OCT)
The thickness of ganglion cell complex (GCC)one month, three months, six months, one year, two years, three yearsThe GCC thickness measured by OCT
Number of eye dropsone month, three months, six months, one year, two years, three yearsThe number of eye drops after surgery.
Adverse eventone month, three months, six months, one year, two years, three yearsAdverse events of each group, such as cornea edma, ocular hypotension, hemorrhage
Mean deviationone month, three months, six months, one year, two years, three yearsThe mean deviation value of Humphery visual filed tests before and after surgery.

Countries

China

Contacts

Primary ContactFeng Gao, Doctor
fenggao@fudan.edu.cn(86)021-64377134

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026